STAT – It was new evidence that, in their understanding of this devastating genetic illness, scientists know only half the story: In addition to being a neurodegenerative disease, it is also neurodevelopmental, starting in the womb.
News-Medical.net – The grant will establish CONNECT-TBI--a program spanning 12 institutions which will study traumatic brain injury (TBI) and related neurodegenerative diseases.
ScienceDaily – Findings may provide insight about development of neurodegenerative conditions like Parkinson's disease.
National Institutes of Health – National Institutes of Health scientists have developed an ultrasensitive new test to detect abnormal forms of the protein tau associated with uncommon types of neurodegenerative diseases called tauopathies.
The Orlando Sentinel – Another crisis is now underway — the one resulting from dementia, or a loss of cognitive ability, whether caused by Alzheimer’s or another neurodegenerative disease. Its scale is unprecedented, and its numbers, already tragic, are growing rapidly.
The Boston Globe – Researchers led by Boston University have taken a step forward in finding a way to diagnose the degenerative brain disease known as CTE in living people, advancing the understanding of an illness that now can only be confirmed after death.
Tech Times – The National Center for Health Statistics reviewed information from all death certificates filed across the country and found that, in 2017, the neurodegenerative disease is the underlying cause of death among 261,914 people. About 46 percent of these deaths were due to Alzheimer's, the most common form of dementia.
NFL — The grants are part of the $40 million commitment the NFL made in 2016 to fund medical research focused on enhancing player health and safety.
Forbes – Novartis touted a pipeline that includes more than 200 programs in clinical development encompassing over 500 ongoing clinical trials with 26 potential blockbusters in late stage development.
ScienceDaily – A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints–molecules that regulate the activity of the immune system–in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Business Wire – NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company developing proprietary natural product-based therapeutics for neurodegenerative complications, announced its official launch, marking the start of its efforts in developing treatments for significant unmet patient needs including diabetic neuropathic pain and Alzheimer’s disease.
Cision – CuraSen is developing small molecule drugs targeting a novel mechanism in the brain to alleviate disabling symptoms and modify disease pathology in patients who suffer from less common (orphan) neurodegenerative disorders as well as Parkinson's Disease and Alzheimer's Disease.